GlassScriptPhysician profile
Nabil Mnayarji
NPI 1427125426
$1,702.91
in general payments reported to CMS, 2019-2025
23 companies · $307 in 2025
The $307 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $684 · 2020: $174 · 2021: $199 · 2022: $137 · 2023: $43.83 · 2024: $158 · 2025: $307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $509.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $508.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $456.27 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $141.98 | 2021-2023 | Xarelto |
| Abbott Laboratories | $137.18 | 2022 | |
| Boston Scientific Corporation | $129.87 | 2025 | Watchman Flx |
| Cvrx, INC. | $121.92 | 2024 | Barostim Neo System |
| Medtronic Vascular, INC. | $90.05 | 2019 | |
| Amgen INC. | $85.26 | 2020 | |
| Zimmer Biomet Holdings, INC. | $65.96 | 2019-2025 | Sternalock Blu System |
| E.R. Squibb & Sons, L.L.C. | $50.91 | 2019-2021 | |
| Clearflow INC. | $50.86 | 2019 | |
| Haemonetics Corporation | $49.79 | 2025 | Teg6s Hemostasis System |
| Astrazeneca Pharmaceuticals LP | $45.11 | 2019 | |
| Lemaitre Vascular, INC. | $39.75 | 2021 | |
| Atricure, INC. | $38.75 | 2025 | Synergy Ablation System, Atricure Cryoice Cryoablation System (Cryo2) |
| Merck Sharp & Dohme LLC | $34.54 | 2024-2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $34.36 | 2025 | Flixene |
| Medtronic, INC. | $28.21 | 2023 | Corevalve Evolut R |
| Urgo Medical North America, LLC | $22.61 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Davol INC. | $21.57 | 2020 | |
| Solventum Corporation | $17.54 | 2024 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Chiesi USA, INC. | $16.77 | 2019 | |
| Kci USA, INC. | $12.38 | 2021 | |
| Ethicon US, LLC | $11.27 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nabil Mnayarji listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.